Concurrent medications that affect potassium balance require consideration: Diuretics (particularly loop and thiazide diuretics) increase renal potassium losses Insulin therapy can shift potassium intracellularly Corticosteroids may promote potassium excretion Laxatives used regularly can contribute to gastrointestinal potassium losses ACE inhibitors, ARBs, and potassium-sparing diuretics (such as spironolactone, eplerenone, amiloride) can increase potassium levels and may complicate management Pre-existing medical conditions may increase susceptibility to electrolyte disturbances: Chronic kidney disease (reduced capacity to regulate potassium) Heart failure (often managed with multiple medications affecting electrolytes) Adrenal insufficiency (impaired aldosterone regulation, typically predisposing to hyperkalaemia) Inflammatory bowel disease (baseline increased gastrointestinal losses) Elderly patients may be at higher risk due to age-related changes in renal function, polypharmacy, and reduced physiological reserve

Faster dose escalation can intensify appetite suppression but increases nausea and side-effect risk without improving the fundamental timeline of weight loss
Kursus Klinische Diabetologie der DDG, Hannover, 26.08.2004
Based on these precise findings, I develop a highly personalized treatment protocol for each patient
The cognitive behavioral therapy lessons were actually useful
The Ach is metabolized by Ach esterase (AChE) enzyme